Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.8%

2 terminated out of 42 trials

Success Rate

91.7%

+5.1% vs benchmark

Late-Stage Pipeline

24%

10 trials in Phase 3/4

Results Transparency

27%

6 of 22 completed with results

Key Signals

6 with results92% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (20)
P 1 (1)
P 2 (3)
P 4 (10)

Trial Status

Completed22
Unknown11
Recruiting4
Terminated2
Withdrawn1
Active Not Recruiting1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT06401863Not ApplicableActive Not RecruitingPrimary

Shared Decision for Drug Interactions in Oral Anticoagulation

NCT04796714Phase 4Recruiting

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

NCT07441382Not ApplicableRecruiting

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

NCT04977076Not ApplicableRecruiting

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

NCT05710562CompletedPrimary

Epidemiological Description of Health Determinants in Italian Anticoagulated Population

NCT04861103Phase 4Recruiting

Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

NCT05065502Not ApplicableCompleted

MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings

NCT04724460Phase 4Completed

Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer

NCT06203795Not ApplicableCompleted

Dialysis Performance of the FX CorAL Membrane

NCT06729034Phase 2Not Yet Recruiting

A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation

NCT06140563Not ApplicableCompleted

Variability in Micro-CT Imaging Results to Quantify Dialyzer Clotting

NCT03614741Phase 4Unknown

Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients

NCT06137794Not ApplicableUnknown

Application of "I-Anticoagulation"in Patients With Atrial Fibrillation

NCT05820854UnknownPrimary

Self-care and Self-efficacy Scale in Oral Anticoagulation Therapy

NCT05645913Unknown

Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation

NCT04681482Completed

Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare

NCT03678506Phase 4Terminated

Apixaban for Extended Anticoagulation (APIDULCIS)

NCT03318393Phase 4Completed

Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO

NCT02777047Not ApplicableCompletedPrimary

Coordination of Oral Anticoagulant Care at Hospital Discharge

NCT03670446Not ApplicableUnknownPrimary

Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants:A Study on Behavioral Patterns

Scroll to load more

Research Network

Activity Timeline